Carbon-iron injection plus radiation for solid tumors
Part of Cancer clinical trials.
This trial tests a new treatment that injects tiny carbon-iron particles directly into a tumor, combined with radiation therapy, to see if it helps control solid tumors. It is for people who are either getting radiation before surgery or as their main treatment when surgery isn't an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and not older than 80.
- You must have a solid tumor (like soft tissue sarcoma or head and neck cancer) that can be treated with radiation therapy.
- You should be generally active and able to care for yourself (ECOG score 0 or 1).
- You must have at least one tumor that can be directly injected with the study drug.
- You can have no more than 5 areas where the cancer has spread (limited metastasis).
- Your heart, liver, kidney, and blood tests must be within acceptable levels, and you must not have a history of iron metabolism disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation, focused high-dose radiation, and an immunotherapy drug (tislelizumab) for people with large, advanced solid tumors that have not responded to standard treatments.
This trial tests a new treatment where immune cells (called macrophage exosomes) are injected directly into your tumor to help your body fight the cancer. It's designed for advanced cancers that have not responded to standard treatments.
This trial tests a new treatment for advanced solid tumors that uses tiny iron particles guided by carbon nanoparticles, injected directly into the tumor. It may be an option if standard treatments have stopped working or aren't available, and you have a tumor that can be safely injected.
This trial tests a new drug that may help people with advanced solid tumors that have not responded to other treatments. The drug is given as an injection and aims to stop cancer growth.
This trial tests an experimental cell therapy for people with advanced solid tumors that have not responded to standard treatments. The therapy uses immune cells from your own tumor, grown in the lab and given back to you, potentially to help your body fight the cancer.
This trial tests if injecting chemotherapy directly into tumors can help people with advanced solid cancers that have stopped responding to standard treatments. It aims to see how safe and effective this approach is.
Hear when a new HNSCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.